Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Peptides synthesized at Eisai modulate active oxygen production in neutrophils

July 25, 2000

Recently issued patent covers new Haemophilus vaccines

July 25, 2000

Novel conjugates for inducing tolerance in xenotransplantation

July 24, 2000

Rights to S. pneumoniae vaccine technology licensed to SB

July 21, 2000

NeisVac-C meningococcal vaccine approved in U.K.

July 21, 2000

AdProTech signs research agreement with Chiron

July 19, 2000

N. meningitidis polypeptides and their use patented by SB

July 18, 2000

Virosome influenza vaccine comparable to subunit vaccine in pediatric CF

July 18, 2000

The former Warner-Lambert claims use of MEK kinase inhibitors for transplant rejection

July 17, 2000

Chiron and Aventis Pasteur team up to promote and market vaccines

July 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.